Investegate announcements from atai Life Sciences, atai Impact Donates to the Multidisciplinary Association for Psychedelic Studies (MAPS) to Support Pioneering Work in Psychedelic Medicine
- Leading non-profit and commercial organizations in psychedelic science united in visions to heal mental health conditions - Donation is from atai Impact, the philanthropic arm of mental health company
atai Impact Donates to the Multidisciplinary Association for Psychedelic Studies (MAPS) to Support Pioneering Work in Psychedelic Medicine- Leading non-profit and commercial organizations in psychedelic science united in visions to heal mental health conditions- Donation is from atai Impact, the philanthropic arm of.
atai Life Sciences Launches Invyxis to Accelerate Discovery of Next-Generation Mental Health TreatmentsInvyxis will add proven medicinal chemistry and comprehensive biological evaluation capabilities to grow atai’s portfolio of new chemical entities (NCEs)Early focus will be on designing unique, novel compound.